Aurinia Pharmaceuticals
€13.02
133
-€0.33-2.47% Today
Statistics
Day High
12.63
Day Low
12.61
52W High
14.08
52W Low
6.24
Volume
80
Avg. Volume
-
Mkt Cap
1.73B
P/E Ratio
30.59
Dividend Yield
-
Dividend
-
Upcoming
Earnings
30AprExpected
Expected EPS
0.195
Actual EPS
N/A
Financials
100.92%Profit Margin
Profitable486.69MRevenue
491.15MNet Income
Analyst Ratings
$13.15Average Price Target
The highest estimate is 15.93.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 33%
Hold 67%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow IKAP.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
GSK
GSK
Mkt Cap94.51B
Abbvie
ABBV
Mkt Cap385.18B
Pfizer
PFE
Mkt Cap140.15B
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
AMGEN
AMGN
Mkt Cap160.66B
Johnson & Johnson
JNJ
Mkt Cap455.04B
Novartis
NVS
Mkt Cap237.61B
Gilead Sciences
GILD
Mkt Cap148.78B
Astrazeneca
AZN
Mkt Cap256.58B
Roche
RHHBY
Mkt Cap258.9B
About
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.
Show more...
CEO
Mr. Peter S. Greenleaf M.B.A.
Employees
130
Country
CA
ISIN
CA05156V1022
WKN
000A1W7D4
Listings
0 Comments
Share your thoughts
FAQ
What is Aurinia Pharmaceuticals stock price today?▼
The current price of IKAP.F is €13.02 EUR — it has decreased by -2.47% in the past 24 hours. Watch Aurinia Pharmaceuticals stock price performance more closely on the chart.
What is Aurinia Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aurinia Pharmaceuticals stocks are traded under the ticker IKAP.F.
Is Aurinia Pharmaceuticals stock price growing?▼
IKAP.F stock has risen by +7.07% compared to the previous week, the month change is a +8.36% rise, over the last year Aurinia Pharmaceuticals has showed a +75.47% increase.
What is Aurinia Pharmaceuticals market cap?▼
Today Aurinia Pharmaceuticals has the market capitalization of 1.73B
When is the next Aurinia Pharmaceuticals earnings date?▼
Aurinia Pharmaceuticals is going to release the next earnings report on April 30, 2026.
What were Aurinia Pharmaceuticals earnings last quarter?▼
IKAP.F earnings for the last quarter are 1.3 EUR per share, whereas the estimation was 0.18 EUR resulting in a +606.15% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Aurinia Pharmaceuticals revenue for the last year?▼
Aurinia Pharmaceuticals revenue for the last year amounts to 486.69M EUR.
What is Aurinia Pharmaceuticals net income for the last year?▼
IKAP.F net income for the last year is 491.15M EUR.
How many employees does Aurinia Pharmaceuticals have?▼
As of April 02, 2026, the company has 130 employees.
In which sector is Aurinia Pharmaceuticals located?▼
Aurinia Pharmaceuticals operates in the Health Care sector.
When did Aurinia Pharmaceuticals complete a stock split?▼
The last stock split for Aurinia Pharmaceuticals was on October 24, 2013 with a ratio of 1:50.
Where is Aurinia Pharmaceuticals headquartered?▼
Aurinia Pharmaceuticals is headquartered in Edmonton, CA.